Long-Term Functional and Oncologic Outcomes of Robot-Assisted Partial Nephrectomy for Cystic Renal Tumors: A Single-Center Retrospective Study

被引:7
作者
Zennami, Kenji [1 ]
Takahara, Kiyoshi [1 ]
Matsukiyo, Ryo [2 ]
Nukaya, Takuhisa [1 ]
Takenaka, Masashi [1 ]
Fukaya, Kosuke [1 ]
Ichino, Manabu [1 ]
Fukami, Naohiko [3 ]
Sasaki, Hitomi [1 ]
Kusaka, Mamoru [3 ]
Toyama, Hiroshi [2 ]
Sumitomo, Makoto [1 ]
Shiroki, Ryoichi [1 ]
机构
[1] Fujita Hlth Univ, Dept Urol, Sch Med, Toyoake, Aichi, Japan
[2] Fujita Hlth Univ, Sch Med, Dept Radiol, Toyoake, Aichi, Japan
[3] Fujita Hlth Univ, Okazaki Med Ctr, Dept Urol, Okazaki, Aichi, Japan
关键词
renal-cell carcinoma; cystic renal mass; kidney neoplasm; partial nephrectomy; robotic; LAPAROSCOPIC PARTIAL NEPHRECTOMY; CELL CARCINOMA; CLASSIFICATION;
D O I
10.1089/end.2020.0994
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To evaluate the outcomes of robot-assisted partial nephrectomy (RAPN) in cystic renal tumors. Materials and Methods: We retrospectively analyzed patients who underwent RAPN for either cystic (n = 46) or solid (n = 271) renal tumors at Fujita Health University between 2010 and 2019. Cystic renal tumors were diagnosed using cross-sectional imaging. Perioperative, oncologic, and functional outcomes were assessed. Results: The median follow-up periods were 38, 41, and 37 months in the total, cystic, and solid groups, respectively. Most patient characteristics were similar among both groups, while the median age of the cystic group was significantly lower than that of the solid group (p = 0.02). Most perioperative variables and complications were comparable between the two groups. There was no significant difference between the groups in perioperative renal function. The estimated glomerular filtration rate preservation rates were 93.1% and 89.2% in the cystic and solid groups, respectively (p = 0.17). The cystic group showed a higher benign histology rate (19.6% vs 7%) and lower Fuhrman grade than the solid group (24.3% vs 15.1% in grade 1, and 73% vs 81.3% in grade 2), although there was no statistically significant difference between the two groups. In the solid group, 10 patients (3.7%) experienced recurrence, and 2 patients (0.7%) died of renal-cell carcinoma, while none of the patients with cystic tumors experienced recurrence. There was no statistically significant difference between the cystic and solid tumors with respect to 5-year recurrence-free survival (p = 0.18), cancer-specific survival (p = 0.55), and overall survival (p = 0.35). Conclusions: RAPN for cystic renal tumors appears to be safe and feasible with perioperative, long-term functional and oncologic outcomes comparable with those in solid tumors. RAPN can be a safe and effective surgical option for cystic renal tumors.
引用
收藏
页码:1006 / 1012
页数:7
相关论文
共 22 条
[1]   Robotic Partial Nephrectomy for Cystic Renal Masses: A Comparative Analysis of a Matched-paired Cohort [J].
Akca, Oktay ;
Zargar, Homayoun ;
Autorino, Riccardo ;
Brandao, Luis Felipe ;
Laydner, Humberto ;
Krishnan, Jayram ;
Samarasekera, Dinesh ;
Li, Jianbo ;
Haber, Georges-Pascal ;
Stein, Robert ;
Kaouk, Jihad H. .
UROLOGY, 2014, 84 (01) :93-98
[2]   Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population-based study [J].
Ani, Ifeanyi ;
Finelli, Antonio ;
Alibhai, Shabbir M. H. ;
Timilshina, Narhari ;
Fleshner, Neil ;
Abouassaly, Robert .
BJU INTERNATIONAL, 2013, 111 (08) :E300-E305
[3]   Renal Mass and Localized Renal Cancer: AUA Guideline [J].
Campbell, Steven ;
Uzzo, Robert G. ;
Allaf, Mohamad E. ;
Bass, Eric B. ;
Cadeddu, Jeffrey A. ;
Chang, Anthony ;
Clark, Peter E. ;
Davis, Brian J. ;
Derweesh, Ithaar H. ;
Giambarresi, Leo ;
Gervais, Debra A. ;
Hu, Susie L. ;
Lane, Brian R. ;
Leibovich, Bradley C. ;
Pierorazio, Philip M. .
JOURNAL OF UROLOGY, 2017, 198 (03) :520-529
[4]   Natural History of Complex Renal Cysts: Clinical Evidence Supporting Active Surveillance [J].
Chandrasekar, Thenappan ;
Ahmad, Ardalan E. ;
Fadaak, Kamel ;
Jhaveri, Kartik ;
Bhatt, Jaimin R. ;
Jewett, Michael A. S. ;
Finelli, Antonio .
JOURNAL OF UROLOGY, 2018, 199 (03) :633-639
[5]   Cystic renal cell carcinoma: a report of 67 cases including 4 cases with concurrent renal cell carcinoma [J].
Chen, Shanwen ;
Jin, Baiye ;
Xu, Liqi ;
Fu, Guanghou ;
Meng, Hongzhou ;
Liu, Ben ;
Li, Jun ;
Xia, Dan .
BMC UROLOGY, 2014, 14
[6]   Comparison of Perioperative Outcomes Between Robotic and Laparoscopic Partial Nephrectomy: A Systematic Review and Meta-analysis [J].
Choi, Ji Eun ;
You, Ji Hye ;
Kim, Dae Keun ;
Rha, Koon Ho ;
Lee, Seon Heui .
EUROPEAN UROLOGY, 2015, 67 (05) :891-901
[7]   Clinicopathologic Outcomes of Cystic Renal Cell Carcinoma [J].
Donin, Nicholas M. ;
Mohan, Sanjay ;
Pham, Hai ;
Chandarana, Hersh ;
Doshi, Ankur ;
Deng, Fang-Ming ;
Stifelman, Michael D. ;
Taneja, Samir S. ;
Huang, William C. .
CLINICAL GENITOURINARY CANCER, 2015, 13 (01) :67-70
[8]   PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[9]   Investigation of the freely available easy-to-use software 'EZR' for medical statistics [J].
Kanda, Y. .
BONE MARROW TRANSPLANTATION, 2013, 48 (03) :452-458
[10]  
Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO